Bivalirudin (Apotex corp)


Welcome to the PulseAid listing for the Bivalirudin drug offered from Apotex corp. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Apotex corp
NON-PROPRIETARY NAME: bivalirudin
SUBSTANCE NAME: BIVALIRUDIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-07-17
END MARKETING DATE: 0000-00-00


Bivalirudin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBivalirudin from Apotex corp
LABELER NAME: Apotex corp
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 2017-07-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60505-6101_fa768c7b-5d35-d496-72d0-7efefe3d736e
PRODUCT NDC: 60505-6101
APPLICATION NUMBER: ANDA204876

Other BIVALIRUDIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex corpBivalirudin
Dr. Reddy’s Laboratories LimitedBivalirudin
Fresenius Kabi USA, LLCBivalirudin
Hospira, Inc.Bivalirudin
Sagent Pharmaceuticalsbivalirudin
Sandozbivalirudin
The Medicines CompanyAngiomax